<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="60425">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01947335</url>
  </required_header>
  <id_info>
    <org_study_id>02358512.7.0000.0068</org_study_id>
    <nct_id>NCT01947335</nct_id>
  </id_info>
  <brief_title>IVUS Guidance to Reduce Contrast in Coronary Angioplasty</brief_title>
  <acronym>MOZART</acronym>
  <official_title>Minimizing cOntrast utiliZAtion With IVUS Guidance in coRonary angioplasTy: The MOZART Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>InCor Heart Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>InCor Heart Institute</source>
  <oversight_info>
    <authority>Brazil: Ethics Committee</authority>
    <authority>Brazil: National Committee of Ethics in Research</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Contrast-induced acute kidney injury (CI-AKI) is an important adverse effect of percutaneous
      coronary interventions. Despite various efforts, very few preventive measures have been
      shown effective in reducing its incidence. The final volume of contrast media utilized
      during the procedure is a well-known independent factor affecting the occurrence of CI-AKI.

      Intravascular ultrasound (IVUS) has been largely used as an adjunctive diagnostic tool
      during percutaneous coronary intervention (PCI). When fully explored, IVUS provides precise
      information for guiding the PCI strategy. IVUS allows accurate vessel and lesion sizing,
      determination of plaque calcification (and the need for pre-stent plaque preparation),
      assessment of post-stent results (including edge dissections and residual lesion, as well as
      stent underexpansion or incomplete apposition). Therefore, IVUS has the potential to reduce
      the utilization of contrast media during PCI.

      In the present study, we hypothesize that IVUS guidance is associated with a significant
      reduction in the volume of contrast media during PCI, in comparison to standard
      angiography-guided intervention.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Anticipated">May 2014</completion_date>
  <primary_completion_date type="Anticipated">November 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Total volume of iodine contrast used during procedure</measure>
    <time_frame>Day 1</time_frame>
    <safety_issue>No</safety_issue>
    <description>Total volume of iodine contrast administered during the index procedure.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical and angiographic success</measure>
    <time_frame>Day 1</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major adverse cardiac events</measure>
    <time_frame>30 days and 6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Composite of death, myocardial infarction or repeat revascularization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of contrast-induced nephropathy</measure>
    <time_frame>7 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>Increase &gt;= 0.5 mg/dl in basal serum creatinine</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Contrast-induced Acute Kidney Injury</condition>
  <condition>Acute Renal Failure</condition>
  <arm_group>
    <arm_group_label>Angiography-guided PCI</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Angiography-guided percutaneous coronary intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IVUS-guided PCI</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intravascular ultrasound guided percutaneous coronary intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>IVUS-guided PCI</intervention_name>
    <description>Intravascular ultrasound guided percutaneous coronary intervention</description>
    <arm_group_label>IVUS-guided PCI</arm_group_label>
    <other_name>Intravascular ultrasound</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Written informed consent

          -  Age &gt;=18 years

          -  Coronary artery disease scheduled for percutaneous intervention

          -  Technical feasibility for intravascular ultrasound to guide coronary angioplasty

          -  Increased risk for contrast-induced acute renal failure (e.g. age &gt; 80 years, female
             gender, diabetes, urgent or emergent procedure priority, diabetes, congestive heart
             failure, increased baseline serum creatinine, decreased calculated or measured
             creatinine clearance, intra-aortic balloon pumping, previous renal transplantation or
             single kidney)

        Exclusion Criteria:

          -  Anticipated technical impossibility for intravascular ultrasound

          -  Unknown baseline renal function

          -  Baseline end-stage renal failure needing dialysis

          -  Acute renal failure with dynamic change in renal function at the time of index
             procedure

          -  Iodine contrast administration &lt;= 72 prior to index procedure

          -  Known allergy to iodine contrast
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pedro A Lemos, MD PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Heart Institute - InCor. University of Sao Paulo Medical School</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Paulo R Soares, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Heart Institute - InCor. University of Sao Paulo Medical School</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Patricia Pereira</last_name>
    <phone>+55 11 2661 5368</phone>
    <email>patricia.pareira@incor.usp.br</email>
  </overall_contact>
  <location>
    <facility>
      <name>Heart Institute - InCor. University of Sao Paulo Medical School</name>
      <address>
        <city>Sao Paulo</city>
        <zip>05403-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Pedro A Lemos, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paulo R Soares, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <lastchanged_date>September 17, 2013</lastchanged_date>
  <firstreceived_date>January 1, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>InCor Heart Institute</investigator_affiliation>
    <investigator_full_name>Pedro A. Lemos</investigator_full_name>
    <investigator_title>Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>Coronary</keyword>
  <keyword>Angioplasty</keyword>
  <keyword>Percutaneous coronary intervention</keyword>
  <keyword>Stent</keyword>
  <keyword>Contrast</keyword>
  <keyword>Acute Renal failure</keyword>
  <keyword>Intravascular ultrasound</keyword>
  <keyword>Prevention</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Acute Kidney Injury</mesh_term>
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
